000			01986 a2200565 4500
005			20250516015043.0
264		0	_c20110328
008			201103s 0 0 eng d
022			_a1538-8514
024	7		_a10.1158/1535-7163.MCT-10-0572 _2doi
040			_aNLM _beng _cNLM
100	1		_aPratap, Jitesh
245	0	0	_aThe histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss. _h[electronic resource]
260			_bMolecular cancer therapeutics _cDec 2010
300			_a3210-20 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aBone Neoplasms _xcomplications
650	0	4	_aBone Resorption _xcomplications
650	0	4	_aBone and Bones _xdiagnostic imaging
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aExtremities _xpathology
650	0	4	_aHistone Deacetylase Inhibitors _xchemistry
650	0	4	_aHumans
650	0	4	_aHydroxamic Acids _xchemistry
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aOsteolysis _xcomplications
650	0	4	_aRadiography
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aTumor Microenvironment _xdrug effects
650	0	4	_aVorinostat
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aAkech, Jacqueline
700	1		_aWixted, John J
700	1		_aSzabo, Gabriela
700	1		_aHussain, Sadiq
700	1		_aMcGee-Lawrence, Meghan E
700	1		_aLi, Xiaodong
700	1		_aBedard, Krystin
700	1		_aDhillon, Robinder J
700	1		_avan Wijnen, Andre J
700	1		_aStein, Janet L
700	1		_aStein, Gary S
700	1		_aWestendorf, Jennifer J
700	1		_aLian, Jane B
773	0		_tMolecular cancer therapeutics _gvol. 9 _gno. 12 _gp. 3210-20
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-10-0572 _zAvailable from publisher's website
999			_c20448732 _d20448732